Press Contact
For media enquiries, please reach out to: contact@aspivix.com
All
- All
- Blog
- In the media
- Press releases
Exploring Femtech
The article explores the "Femtech" industry, which focuses on innovative solutions for women's health issues. In the Historic Inequality in Medicine paragraph, Aspivix's solution is introduced as having finally developed a device that could...
New Cervical Device Designed for Gentle Gynecology
Check out a new cervical device designed as an Alternative to the traumatic tenaculum. Carevix™ is clinically proven to reduce pain and bleeding during Transcervical Procedures such as an IUD insertion. https://youtu.be/hY6XOHOMweo
Aspivix Selected as Finalist for the 2024 Digital Health Hub Foundation: Digital Health Awards
Los Angeles (United States) - Aspivix is excited to announce its selection as a Finalist for the prestigious 2024 Digital Health Hub Foundation: Digital Health Awards. Aspivix was selected as a Finalist in...
Aspivix and Tia Partner to Enhance IUD procedures with Carevix™ across the USA
Epalinges, Switzerland/Los Angeles, USA – September 19, 2024 - In a groundbreaking partnership aimed at improving women's health, ASPIVIX, a leading innovator in gynecological and fertility solutions, and Tia women's health clinics,...
CDC issues new guidelines on pain management for IUD procedures
With IUDs growing in popularity, the CDC is now recommending that doctors provide pain management counseling for the procedure. Dr. Celine Gounder explains what this change means for women considering this highly...
Aspivix Announces MHRA Approval for the Groundbreaking Cervical Stabilizer Carevix™ for a painless contraceptive care in the United Kingdom
Epalinges, Switzerland – August 26, 2024 - In a significant stride towards transforming women's healthcare, Aspivix, a leading innovator in gynecological solutions, is thrilled to announce that its pioneering device, Carevix™, has...
